Asset Details
Do you wish to reserve the book?
Quadratus Lumborum Block III for Postoperative Pain After Percutaneous Nephrolithotomy
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Quadratus Lumborum Block III for Postoperative Pain After Percutaneous Nephrolithotomy
Do you wish to request the book?
Quadratus Lumborum Block III for Postoperative Pain After Percutaneous Nephrolithotomy
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Quadratus Lumborum Block III for Postoperative Pain After Percutaneous Nephrolithotomy
2018
Overview
Objective: An effective pain control is important in early mobilization and returning to normal daily life following percutaneous nephrolithotomy (PCNL) operations. The use of an intraoperative local anaesthetic or postoperative analgesic has been reported for pain control in PCNL. Transmuscular quadratus block (QLB III) is a regional anaesthetic technique applied under ultrasound guidance. The aim of this study was to investigate the effectiveness of QLB III on postoperative pain in PCNL. Methods: This prospective, randomized, double-blinded study was carried out at the Dr Ersin Arslan Training and Research Hospital between December 2016 and March 2017. The QLB III block was administered to a total of 44 patients who had undergone elective PCNL under spinal anaesthesia. While half of the patients (Group S, n=22) received 0.2 cc kg-1 of 0.9% saline, the other half (Group Q, n=22) received 0.2 mL kg-1 of 0.0125 isobaric bupivacain with QLB III. For all patients, the pain level was measured using the visual analog scale (VAS), and the morphine consumptions through patient-controlled analgesia (PCA) were recorded at the postoperative 4, 8, 12, 24, and 48 hours. Results: The postoperative VAS was found to be statistically significantly higher at the 8th, 12th, and 24th hour in Group S (p<0.05). The postoperative morphine consumption was determined to be statistically significantly higher at the 4th, 8th, 12th, and 24th hour in Group S (p<0.05). Conclusion: The QLB III was observed to be effective in pain control and reducing morphine consumption during the postoperative 48 hours follow-up after PCNL.
Publisher
Aves Yayincilik Ltd. STI
Subject
